UniProt ID | AK1C4_HUMAN | |
---|---|---|
UniProt AC | P17516 | |
Protein Name | Aldo-keto reductase family 1 member C4 | |
Gene Name | AKR1C4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 323 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Catalyzes the transformation of the potent androgen dihydrotestosterone (DHT) into the less active form, 5-alpha-androstan-3-alpha,17-beta-diol (3-alpha-diol). Also has some 20-alpha-hydroxysteroid dehydrogenase activity. The biotransformation of the pesticide chlordecone (kepone) to its corresponding alcohol leads to increased biliary excretion of the pesticide and concomitant reduction of its neurotoxicity since bile is the major excretory route.. | |
Protein Sequence | MDPKYQRVELNDGHFMPVLGFGTYAPPEVPRNRAVEVTKLAIEAGFRHIDSAYLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWCTFFQPQMVQPALESSLKKLQLDYVDLYLLHFPMALKPGETPLPKDENGKVIFDTVDLSATWEVMEKCKDAGLAKSIGVSNFNCRQLEMILNKPGLKYKPVCNQVECHPYLNQSKLLDFCKSKDIVLVAHSALGTQRHKLWVDPNSPVLLEDPVLCALAKKHKQTPALIALRYQLQRGVVVLAKSYNEQRIRENIQVFEFQLTSEDMKVLDGLNRNYRYVVMDFLMDHPDYPFSDEY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Acetylation | ----MDPKYQRVELN ----CCCCCCEEECC | 50.15 | 7668211 | |
23 | Phosphorylation | MPVLGFGTYAPPEVP EEEECCCCCCCCCCC | 17.78 | 26356563 | |
24 | Phosphorylation | PVLGFGTYAPPEVPR EEECCCCCCCCCCCC | 19.93 | 83949 | |
39 | Ubiquitination | NRAVEVTKLAIEAGF CCHHHHHHHHHHHCC | 40.89 | 33845483 | |
53 | Phosphorylation | FRHIDSAYLYNNEEQ CCEEEEEEEECCHHH | 17.42 | 20561399 | |
67 | Phosphorylation | QVGLAIRSKIADGSV HHHEEEHHHCCCCCC | 23.46 | - | |
68 | Ubiquitination | VGLAIRSKIADGSVK HHEEEHHHCCCCCCC | 31.87 | - | |
73 | Phosphorylation | RSKIADGSVKREDIF HHHCCCCCCCHHHCE | 25.64 | 28857561 | |
75 | Acetylation | KIADGSVKREDIFYT HCCCCCCCHHHCEEE | 52.33 | 19608861 | |
75 | Sumoylation | KIADGSVKREDIFYT HCCCCCCCHHHCEEE | 52.33 | - | |
75 | Ubiquitination | KIADGSVKREDIFYT HCCCCCCCHHHCEEE | 52.33 | 24816145 | |
75 | Sumoylation | KIADGSVKREDIFYT HCCCCCCCHHHCEEE | 52.33 | - | |
81 | Phosphorylation | VKREDIFYTSKLWCT CCHHHCEEEEEEEHH | 15.50 | 22817900 | |
82 | Phosphorylation | KREDIFYTSKLWCTF CHHHCEEEEEEEHHC | 14.50 | 27251275 | |
83 | Phosphorylation | REDIFYTSKLWCTFF HHHCEEEEEEEHHCC | 17.86 | 22617229 | |
161 | Acetylation | CKDAGLAKSIGVSNF HHHCCCHHHHCCCCC | 47.88 | 19608861 | |
161 | Ubiquitination | CKDAGLAKSIGVSNF HHHCCCHHHHCCCCC | 47.88 | - | |
162 | Phosphorylation | KDAGLAKSIGVSNFN HHCCCHHHHCCCCCC | 20.97 | 20873877 | |
166 | Phosphorylation | LAKSIGVSNFNCRQL CHHHHCCCCCCHHHH | 30.41 | - | |
179 | Ubiquitination | QLEMILNKPGLKYKP HHHHHHCCCCCCCCC | 36.70 | 22817900 | |
183 | Ubiquitination | ILNKPGLKYKPVCNQ HHCCCCCCCCCCCCE | 58.08 | 22817900 | |
184 | Phosphorylation | LNKPGLKYKPVCNQV HCCCCCCCCCCCCEE | 26.10 | 20561411 | |
185 | Ubiquitination | NKPGLKYKPVCNQVE CCCCCCCCCCCCEEE | 29.41 | 22817900 | |
196 | Phosphorylation | NQVECHPYLNQSKLL CEEECCCCCCHHHHH | 8.46 | 17924679 | |
200 | Phosphorylation | CHPYLNQSKLLDFCK CCCCCCHHHHHHHHC | 24.97 | 46161739 | |
201 | Acetylation | HPYLNQSKLLDFCKS CCCCCHHHHHHHHCC | 43.22 | 24886175 | |
201 | Ubiquitination | HPYLNQSKLLDFCKS CCCCCHHHHHHHHCC | 43.22 | - | |
201 | Malonylation | HPYLNQSKLLDFCKS CCCCCHHHHHHHHCC | 43.22 | 26320211 | |
206 | S-palmitoylation | QSKLLDFCKSKDIVL HHHHHHHHCCCCEEE | 4.93 | 29575903 | |
207 | Acetylation | SKLLDFCKSKDIVLV HHHHHHHCCCCEEEE | 61.61 | 19608861 | |
207 | Ubiquitination | SKLLDFCKSKDIVLV HHHHHHHCCCCEEEE | 61.61 | 29901268 | |
208 | Phosphorylation | KLLDFCKSKDIVLVA HHHHHHCCCCEEEEE | 36.42 | 17929957 | |
209 | Ubiquitination | LLDFCKSKDIVLVAH HHHHHCCCCEEEEEE | 36.65 | - | |
221 | Phosphorylation | VAHSALGTQRHKLWV EEECCCCCCCCCEEC | 24.23 | 17929957 | |
232 | Phosphorylation | KLWVDPNSPVLLEDP CEECCCCCCCCCCCH | 23.05 | 26657352 | |
246 | Ubiquitination | PVLCALAKKHKQTPA HHHHHHHHHCCCCHH | 57.15 | 29967540 | |
246 | Acetylation | PVLCALAKKHKQTPA HHHHHHHHHCCCCHH | 57.15 | 19608861 | |
247 | Acetylation | VLCALAKKHKQTPAL HHHHHHHHCCCCHHH | 50.88 | 19809417 | |
247 | Ubiquitination | VLCALAKKHKQTPAL HHHHHHHHCCCCHHH | 50.88 | - | |
270 | Ubiquitination | RGVVVLAKSYNEQRI CCCEEEEECCCHHHH | 49.68 | 29901268 | |
270 | Succinylation | RGVVVLAKSYNEQRI CCCEEEEECCCHHHH | 49.68 | 23954790 | |
270 | Acetylation | RGVVVLAKSYNEQRI CCCEEEEECCCHHHH | 49.68 | 25825284 | |
272 | Phosphorylation | VVVLAKSYNEQRIRE CEEEEECCCHHHHHH | 23.24 | - | |
290 | Phosphorylation | VFEFQLTSEDMKVLD EEEEECCHHHHHHHH | 39.94 | 69005589 | |
305 | Phosphorylation | GLNRNYRYVVMDFLM CCCCCCCEEEEEHHH | 6.24 | 50564483 | |
317 | Phosphorylation | FLMDHPDYPFSDEY- HHHCCCCCCCCCCC- | 15.61 | 50564493 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AK1C4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AK1C4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AK1C4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PXDC2_HUMAN | PLXDC2 | physical | 26186194 | |
PXDC2_HUMAN | PLXDC2 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
614279 | 46,XY sex reversal 8 (SRXY8) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-75 AND LYS-270, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-196, AND MASSSPECTROMETRY. |